Development of therapy of Alzheimers disease with iPS cell-derivedmacrophages
Project/Area Number |
23659158
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
General medical chemistry
|
Research Institution | Kumamoto University |
Principal Investigator |
SENJU Satoru 熊本大学, 大学院・生命科学研究部, 准教授 (50274709)
|
Research Collaborator |
TAKAMATSU Koutaro 熊本大学, 大学院・生命科学研究部, 大学院・・生、医員
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | アルツハイマー病 / iPS 細胞 / マクロファージ / アミロイドβ / iPS細胞 / 治療 / 細胞治療 / アミロイドベータ / 疾患モデルマウス |
Research Abstract |
The purpose of this study is to generate macrophages with acapacity to degrade or remove amyloid-・protein, which is known to be the causative agentof Alzheimer ’ s disease.Before this project, we had established a technology to generate functionalphagocytes (macrophages) from mouse and human iPS cells. In the current study , wegenerated macrophages expressing Fc-receptor-fused form of single chain antibody specificto amyloid-・. In addition, we made macrophages expressing neprilysin, a protease reportedto be highly potent in degradation of amyloid-・. We administered the genetically modifiediPS cell-derived macrophages into model mice of Alzheimer ’ s disease, and evaluate whetherthey could reduce the level of amyloid-・in vivo.
|
Report
(3 results)
Research Products
(3 results)
-
[Journal Article] Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy2011
Author(s)
Senju, S., Haruta, M., Matsumura, K., Matsunaga, Y., Fukushima, S., Ikeda, T., Takamatsu, K., Irie, A., Nishimura, Y.
-
Journal Title
Gene Therapy
Volume: 18
Issue: 9
Pages: 874-883
DOI
Related Report
Peer Reviewed
-
[Journal Article] Immunotherapy with pluripotent stem cell-derived dendritic cell2011
Author(s)
Senju, S., Matsunaga, Y., Fukushima, S., Hirata, S., Motomura, Y., Fukuma, D., Matsuyoshi, H., Nishimura, Y.
-
Journal Title
Seminars in Immunopathology
Volume: 33
Issue: 6
Pages: 603-612
DOI
NAID
Related Report
Peer Reviewed
-